The Inflate Study; Defining the Soft Palate in the Upper Airway Flow Pathway
NCT ID: NCT06738589
Last Updated: 2025-03-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
50 participants
INTERVENTIONAL
2025-03-25
2027-08-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* How does soft palate anatomy change in different body positions?
* What is the impact of positive pressure therapy, in the form of non-invasive ventilation (NIV) on soft palate anatomy? Researchers will compare MRI data without positive pressure to with positive pressure imaging to see if the addition of positive pressure impacts the size and shape of the soft palate.
Researchers will also utilize measures of upper airway resistance to assess the impact of soft palate anatomy of airflow dynamics.
Participants will be asked to:
* Lie inside an MRI scanner for up to 90 minutes (including breaks), in different body positions
* Undergo NIV therapy for 5-10 minutes while breathing normally inside an MRI scanner
* Have their upper airway resistance measured, in different body positions
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of EPAP Device on Emphysema and Lung Bullae
NCT04742114
Pilot Evaluation Comparing Regional Distribution of Ventilation During Lung Expansion Therapy
NCT03083379
The Evaluation and Treatment of Elevated Left-Sided Filling Pressures by Balloon Inflation Within the IVC
NCT02984631
Study of AffloVest in At-Risk Respiratory Patients During COVID-19 Pandemic
NCT04654481
Visualization of Inspiratory Effort and Respiratory Mechanics to Promote Lung- and Diaphragm Protective Ventilation
NCT05459116
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
SEQUENTIAL
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
MRI without positive pressure therapy
Healthy volunteers having their upper airway scanned with MRI without the addition of positive airway pressure therapy (NIV)
No interventions assigned to this group
MRI with positive pressure
Healthy volunteers having their upper airway scanned with MRI with the addition of positive airway pressure therapy (NIV)
non-invasive ventilation
Non-invasive ventilation adds positive pressure to the upper airway via a mask on the face.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
non-invasive ventilation
Non-invasive ventilation adds positive pressure to the upper airway via a mask on the face.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Willing and able to consent to the study
Exclusion Criteria
* Contraindications for NIV (such as pneumothorax)
* No history of lung or upper airway disease
* Claustrophobia
* Symptoms of a cold, flu, or significant congestion, within the last 3 days
* Self-reported confirmed or suspected pregnancy
* Palatal abnormalities or previous upper airway surgery (such as cleft palate and/or UPPP)
* Prior major head or neck surgery with or without irradiation (such as radiotherapy of cutaneous cancers, robotic surgery for an oropharyngeal cancer)
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The University of Auckland
UNKNOWN
Fisher and Paykel Healthcare
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Alys Clark
Role: PRINCIPAL_INVESTIGATOR
University of Auckland, New Zealand
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Auckland
Auckland, , New Zealand
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
U1111-1315-8696
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.